Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Parents of Kids with Rare Disease Lead Urgent Push for Cure

Grace Science Foundation
Posted on: 12 Apr 18
Parents of Kids with Rare Disease Lead Urgent Push for Cure Global Family Advisory Board to Aid Critical Race to Cure NGLY1 Deficiency

PR Newswire

SAN FRANCISCO, April 12, 2018

SAN FRANCISCO, April 12, 2018 /PRNewswire/ -- The Grace Science Foundation ("GSF") announced the formation of their global Family Advisory Board, aiming to give a voice to families of patients suffering from NGLY1 Deficiency, a rare genetic disorder with devastating and debilitating effects. The new advisory board is one of several new initiatives GSF founders Kristen and Matt Wilsey are implementing to address the grim realities faced by rare disease patients; research is almost nonexistent and patients are siloed in their respective parts of the world.

"Global collaboration and community are essential to finding an urgently-needed cure," remarked Matt Wilsey, "not only does it empower patients' families to take part in this critical mission, but also it enables us to provide NGLY1 researchers with quick, accessible data, from a diverse group of patients." Diversity is key in this initiative, Wilsey noted, with the advisory board consisting of 20 board members (10 mothers and 10 fathers) from 9 countries, including Turkey, Germany, India, China and the United States.

NGLY1 Deficiency is a genetic disorder that affects many body systems, causing seizures, delayed development, movement abnormalities, liver dysfunction, eye abnormalities, and a reduction or absence of tears. Many families feel they're sitting on the sidelines, helplessly watching their children experience the devastating effects of the disorder, but now they get to play a central role in decision-making processes. Key among their considerations and contributions:

  • Focusing GSF researchers on the most important and impactful aspects of the disease
  • Providing early feedback on therapeutic approaches up for consideration to ensure that the most relevant patient symptoms are being targeted
  • Helping to spread NGLY1 global awareness and increase support

The Grace Science Foundation is a not-for-profit organization, whose mission is to cure NGLY1 Deficiency by pioneering approaches to scientific discovery that are faster, less expensive and more collaborative. For more information, visit


View original content with multimedia:

SOURCE Grace Science Foundation

PR Newswire

Last updated on: 12/04/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.